Eileen Sales
Obstetrics & Gynecology · Gastonia, NCNPI 1518922244
Payments from drug & device makers
Across 178 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$970
- Pfizer$393
- Myovant Sciences Inc.$179
- Exeltis, USA Inc.$171
- Avion Pharmaceuticals$165
- Therapeuticsmd, Inc.$134
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,08798%
- Education$552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $970 |
| Pfizer | 24 | $393 |
| Myovant Sciences Inc. | 6 | $179 |
| Exeltis, USA Inc. | 11 | $171 |
| Avion Pharmaceuticals | 10 | $165 |
| Therapeuticsmd, Inc. | 9 | $134 |
| Mayne Pharma Commercial LLC | 6 | $117 |
| Mylan Pharmaceuticals Inc. | 7 | $93 |
| Novo Nordisk | 5 | $89 |
| Merck | 6 | $84 |
| Aspira Women's Health Inc | 1 | $75 |
| Bayer | 4 | $72 |
| Shield Therapeutics Inc | 3 | $57 |
| AMAG Pharmaceuticals, Inc. | 3 | $55 |
| Lupin Inc. | 4 | $54 |
| Ascend Therapeutics US, LLC | 3 | $43 |
| Coopersurgical, Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $36 |
| Minerva Surgical, Inc | 1 | $36 |
| Radius Health, Inc. | 1 | $27 |
| Agile Therapeutics, Inc. | 2 | $26 |
| Duchesnay USA Incorporated | 2 | $26 |
| Mycovia Pharmaceuticals, Inc. | 1 | $24 |
| Scynexis, Inc. | 1 | $24 |
| Millicent US Inc | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $14 |
| Organon | 1 | $14 |
| Novum Pharma, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$102
How this compares
$3,141 in reported general payments places this provider in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SlyndDrospirenone | 11 | $2,294 |
| ValacyclovirValacyclovir Hcl | 17 | $1,240 |
| Estradiol | 14 | $363 |
| Raloxifene Hcl | 12 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Exeltis, USA Inc.Slynd | $171 | $2,29411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
Other obstetrics & gynecology in Gastonia
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Robert LittletonRaleigh$976K
- Donald HornerCharlotte$907K
- Rebecca Dunsmoor SuMorrisville$837K
- Ann CollinsRaleigh$701K
- Kathryn PattenHendersonville$550K
- Mohamad Mehdi ParvaElizabeth City$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.